ALL vs DNTH · P/E 4.9, $56.89B cap vs rev $6.2M
The Allstate Corporation (ALL) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
ALL does not have a complete income-statement cache yet.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the ALL and DNTH stock pages for the full models.
Not investment advice.